Connect with us

Cannabis News

Former health execs accused of medical pot smuggling in Minnesota

Published

on

pot smuggling

After months of legal battles over the felony drug charges against the former chief medical officer of Vireo Health, Dr. Laura Bultman, and Vireo’s downtown White Plains dispensary, has been upheld.

A Court of Appeals in Minnesota upheld the charges rejecting the officers’ bid to toss the charges.  The appellate decision means that a trial is more likely now.

The Accusations

The two ex-Vireo senior execs were accused of smuggling medical marijuana from Minnesota to New York. The accusations note that the two used the firm’s armored automobile to move medicated cannabis oil between two states illegally.

After reviewing the case as to whether the laws addressed the smuggling of medical pot across the two-state borders well enough, the court ruled that the law didn’t allow the transfer.

The Legal Argument

According to the Minnesota regulations, the apparent smuggling case turns out to point out various legal arguments. For instance, the first argument could be either that some criminals desperately smuggled the medical cannabis in the armored SUV packed with almost $500,000 of cannabis oil.

The other scenario is that maybe respected corporate officers would have transported (behind the masks) the state-licensed medical cannabis from the Minnesota-based company to the affiliate in New York.

Some aspects of the case also have few other connections to the New York State’s medical cannabis program, like allegations that the cannabis oil was illegally sold to patients which were later tested at the state government’s Wadsworth Lab.

The Department of Health in New York, which oversees the cannabis program, reported that it was independently investigating the smuggling allegations and said to release the findings when the case concludes.

 The alleged smuggling could indeed be illegal according to the Appellate Court. The two officers are charged with transferring medical cannabis to some unauthorized person.

Nevertheless, the case has implications for the growing cannabis industry in Minnesota and New York. Perhaps, it has exposed some potential holes in the efforts the government is putting into preventing medical cannabis from crossing the state borders. These scenarios increase the threat of the federal Drug Enforcement Administration raids on the companies licensed by the state laws.

For the latest marijuana industry news updates and the hottest MJ stocks, sign up below!

Photo by Caio Queiroz from Pexels

Continue Reading
Click to comment

Cannabis News

Why the ACMPR Is So Popular with Medical Marijuana Patients in Canada

Published

on

ACMPR

Depending on your home country, accessing medical marijuana may just be easier than ever for you. This is the case for North Americans, Canadians in particular. Since the early 2000s, Canada has been successfully implementing a medical marijuana program for patients called the ACMPR. 

Although this program (also referred to as the MMPR and MMAR in the past) has been around in some form or another for decades, it is continuing to grow in popularity. But why? It’s not just because Canadians want an excuse to grow cannabis plants from home… 

What Is the ACMPR?

Before discussing the growing popularity of the ACMPR program, it’s important to have a solid understanding of what it actually is. ACMPR stands for Access to Cannabis for Medical Purposes Regulations. For those who are eligible and have a valid medical condition that requires the use of cannabis for treatment, the ACMPR allows for easy access to cannabis. 

Not only does it allow medical patients to easily access medical-grade marijuana from licensed producers throughout the country, but it allows patients to cultivate their own plants from home. Unlike the recreational cannabis laws which allow citizens to grow no more than 4 plants from home, the ACMPR determines plant counts based on medical needs. 

Canadians who use the ACMPR license to grow from home have a predetermined plant count based on the number of grams prescribed per day. For example, if you receive a prescription…

Continue Reading

Cannabis News

Why Buy From Marijuana Seed Banks?

Published

on

marijuana seed banks

If you’re interested in growing marijuana and live in a state that allows its cultivation, then you might want to consider buying seeds from seed banks. Some of the best cannabis get cultivated outside the country, which means that, sometimes, you have to find a seed bank that ships to the US. 

There are a lot of options when it comes to sources for marijuana seeds online. However, not all of them can ship to the US due to strict regulations in the country. Thus, it’s best to find a legit seed bank that can process orders from United States customers.  

Avoid transacting with other sources aside from seed banks. If you do so, you run the risk of receiving low-quality products, wasting your money in the end. Look for a company with positive feedback and has a proven history of dealing with US customers. Some of the most popular ones include Seedsman and I Love Growing Marijuana (IGLM). You can check out GreenBudGuru’s Seedsman review and their review of other companies to find the best fit for your needs.

If you’re looking to get your seeds online, below are some reasons you should buy marijuana seeds from a trusted and reliable marijuana seed banks.

You Don’t Have Any Other Option

As mentioned above, some states in the US still don’t allow local buying and selling of marijuana, even if medical marijuana consumption has already gained momentum. If…

Continue Reading

Cannabis News

22nd Century Group Inc (NYSE:XXII): 3 Reasons You May Want To Buy The Stock This Month

Published

on

NYSE:XXII

The tobacco industry is huge and growing. The cannabis industry is already booming yet it is only in the early stages of development and the future looks incredibly bright as more countries legalize pot. 22nd Century Group Inc (NYSE:XXII) is the stock that offers investors the chance to own the best of both tobacco and cannabis worlds.

The stock currently trades at $1.00/share. But that is not where it belongs as that is its lowest watermark. As recently as September, NYSE:XXII was trading above $2.40/share.

About NYSE:XXII

For investors who may have just come across 22nd Century Group for the very first time, here is a brief profile of the company. 22nd Century Group is a plant biotechnology company and a leader in tobacco harm reduction. It has also set its sight on the legal hemp and cannabis industries. In the tobacco space, NYSE:XXII has developed a low-nicotine tobacco plant variety. In the hemp/cannabis space, the company is working to develop hemp and cannabis plants with specific desirable qualities.

If you are looking to have a footing in both tobacco and cannabis industries, here are three reasons you may want to buy NYSE:XXII.

  • 22nd Century Group on track to take control of CBD products maker Panacea Life Sciences

On December 3, 22nd Century…

Continue Reading

MJ Stocks